The measurement of concentrations of drugs and endogenous substances is widely The data originate from a current project on biomarker concentration assessment in the plasma of patients and healthy controls. All subjects had consented into biomarker assessments and the study followed the Declaration of Helsinki on Biomedical Research Involving Human Subjects including approval from the Ethics Committee of the
in all probes of a particular assay run may pass undetected when using standard methods of data quality check. It is shown that the use of different data visualizations that emphasize different views of the data may enhance the detection of systematic laboratory errors. A dotplot of single data in the order of assay is proposed that provides an overview on the data range, outliers and a particular type of systematic errors where similar values are wrongly measured in all probes.
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The measurement of concentrations of drugs or endogenous substances in biological materials plays a major role in pharmacologic research. The reliability of the measurements is of crucial importance. Therefore, quality control is routinely implemented in the workflow of analytical laboratories. Standards of biomedical data reporting comprise a variety of measures for assay error detection 1 including summary statistics for plausibility checks and data visualizations. 2 Nevertheless, further improvements of the detection of assay errors are desirable. In the present report, a real-life example is given that laboratory errors may pass undetected with advised methods of data exploration. A simple solution employing the application of data science-based visualizations, which may enhance the detection of laboratory errors, is proposed.
The data originate from a current project on biomarker concentration assessment in the plasma of patients and healthy controls. All subjects had consented into biomarker assessments and the study followed the Declaration of Helsinki on Biomedical Research Involving Human Subjects including approval from the Ethics Committee of the Medical Faculty of the Goethe-University, Frankfurt, Germany. However, for reasons of nondisclosure, the present technical observation will be reported using anonymized data rescaled with a constant numerical factor. Three different plasma-derived biochemical markers are reported, arbitrarily named "Lab1", "Lab2" and "Lab3". While one of the markers was assessed probably without laboratory errors (named "Lab1"; Figure 1 ), the two other markers carry systematic assay errors at different degrees as verified in assay repetitions.
Specifically, in the measurements of the second marker, in a particular assay run, the laboratory produced always the same value ("Lab2", data marked with a red ellipse in Figure 1 ), whereas the third marker ("Lab3") was usually measured at a concentration of zero except for one day when the laboratory produced highly variable values above the lower limit of quantification (Figure 1 right panel). A common approach to data quality check is the application of basic descriptive statistics (Table 1) . This can provide plausibility checks when comparing the observed values with the expectations of a domain expert, who knows the physiological or pathophysiological value range of the parameters or the magnitude and direction of expected differences among, for example, clinically relevant groups.
In the present example, an assay error in "Lab3" would have been suggested from the median and mean values of zero or almost zero, respectively. However, the error in "Lab2" in particular the similar values obtained in a particular assay run would pass undetected as the descriptive statistics appear to be unsuspicious. whereas the more subtle pathologies of the datasets, that is, same values during a particular assay run or during a whole day for "Lab2"
and "Lab3" respectively, were not visualized by these standard plots. F I G U R E 1 Dotplot of plasma concentrations of three different biochemical markers (arbitrarily named "Lab1", "Lab2" and "Lab3"). The dots display the single data, sorted in order of consecutive assay (upper line). Two different clinical phenotypes are included with a distribution of n = 100/100. In the parameter "Lab2" a short temporal window (red ellipse) was detected during which all measured concentrations had wrongly the same numerical value. In "Lab3" all measurements were zero except for one assay day during which highly variable results were produced. The detection of these errors became impossible when the temporal succession of assay was destroyed (bottom line)
T A B L E 1 Descriptive statistical analysis of the three laboratory parameters, originating from an actual scientific project but presently arbitrarily named "Lab1", "Lab2" and "Lab3" The calculations were made using the "describe" command of the R library "psych" This is a kernel density estimator that has been developed with the focus to be particularly suitable for the discovery of groups in the data. 3 An implementation can be found in the R package pathologies such as the same values in all probes obtained during a particular assay run were clearly evident. Importantly, the data need to be plotted in the order of assay; if this succession was destroyed (Figure 1 bottom line) , the short repetition of the same value in "Lab2" disappeared, and the values above zero in "Lab3" do not anymore hint at a systematic laboratory error but appear simply as noise or outliers. 
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